VTA real-time biofeedback with 7-Tesla MRI in depression
Official title: Mechanisms of Repeated Real-time Biofeedback With 7-Tesla MRI in Depression
Run by University of Oxford · NCT07694076 · Data updated 2026-11-12
This study tests whether people with major depressive disorder can learn to modulate their brain's reward center (the VTA) using real-time feedback during 7-Tesla MRI sessions, to see if it changes mood and motivation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford) |
| Status | Recruiting |
| Started | December 2026 |
| Main results expected | June 2031 |
| Study ends | June 2033 |
| Registry record updated | November 3, 2026 |
| Trial ID | NCT07694076 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18-65 with a current major depressive episode meeting DSM-5 criteria, able to participate in MRI procedures and English-language assessments.
✕Probably not a fit
Individuals with contraindications to MRI, recent antidepressant changes, or significant comorbidities may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This mechanistic study will enroll 60 adults with major depressive disorder and randomize them to active or sham real-time biofeedback while they attempt to self-regulate ventral tegmental area activity using cognitive strategies during 7T MRI sessions. Participants will complete two training sessions with feedback while viewing visual cues, aiming to characterize changes in mood, motivation-related measures, and neural connectivity. The trial builds on prior work showing VTA self-regulation is feasible and seeks to clarify relationships between targeted VTA modulation and clinical/neural outcomes in a larger sample. Outcomes will include mood and motivation scales as well as fMRI-derived measures of brain activity and functional connectivity.
Why it matters
Potential benefit: If successful, the approach could provide a new, mechanism-based option for targeting motivation and reward-related symptoms in depression.
How similar studies have gone: Prior work has shown feasibility of VTA self-regulation with real-time feedback, supporting the potential for benefit in this larger, repeated-training study.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female aged 18-65 years; * Meets DSM-5 criteria for major depressive disorder (MDD) as determined by the Structured Clinical Interview for DSM-5 Axis Disorders (SCID) or the Mini International Neuropsychiatric Interview (MINI); with a current major depressive episode; as conducted in a research-based non-clinical setting. * Participants must have a level of understanding of the English language sufficient to agree to all tests and examinations required by the study and must be able to participate fully in the informed consent process. Exclusion Criteria: * Current or history of schizophrenia or other psychotic disorder, neurodevelopmental disorder, neurocognitive disorder or cognitive impairment * Active substance use disorder within the past 1 year; * Any unstable medical illnesses; * Women who are pregnant; * Any contraindications to MRI * Antidepressant medication initiated within 2 weeks of the Baseline Assessment and concomitant use of any other medication with central nervous system activity during active participation; * Active suicidal intent or plan.
Where it's running
-
Oxford Centre for Integrative Neuroimaging (OxCIN) FMRIB, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital
Oxford, United Kingdom Recruiting
Study contacts
- Principal investigator: Laurel S Morris, Dr — University of Oxford
- Study coordinator: Laurel S Morris, Dr
- Email: laurel.morris@ndcn.ox.ac.uk
- Phone: 01865 (6)16577
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Emotional Reactivity in Severe Alcohol Use Disorder and Depression Using Eye-Tracking and Physiological Measures
This study tests how people with severe alcohol use disorder, major depressive disorder, both conditions, or neither, recognize and react to emotions using eye-tracking and physiological data.
-
Temporally Interfering Electrical Stimulation for Major Depressive Disorder
This study tests whether noninvasive temporally interfering electrical stimulation can help people with major depressive disorder.
-
Affective Cognitive Training for mood disorders and their close relatives
A six-week program combining virtual reality and computer exercises tests whether affective cognitive training helps people with mood disorders and their unaffected first-degree relatives.
-
ALKS 7290 added to antidepressants for adults with major depression
This study tests whether ALKS 7290, taken with current antidepressants, helps adults with major depressive disorder.
-
French Minds: a French, Multimodal Cohort Study of Severe Psychiatric Disorders and Healthy Controls
This study tests whether people with mood, psychotic, or autism disorders can be grouped into more similar subtypes based on social withdrawal and anhedonia, across ages 15 to 60.
-
EEG-Guided TMS for Adults With Depression
This study tests whether delivering intermittent theta burst stimulation (iTBS) timed to brain waves using EEG can improve treatment for adults with major depressive disorder who have not responded to usual antidepressants.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.